MYC通过促进pRB1降解来诱导CDK4/6抑制剂的耐药性
Jian Ma1,2,3, Lei Li1,2,3, Bohan Ma1,2,3
1Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Nature communications
|February 29, 2024
概括
在癌症中,MYC放大会导致对CDK4/6抑制剂 (CDK4/6i) 的抗性. 一种新的化合物,A80.2HCl,降解MYC,恢复对CDK4/6i的敏感性,并减少瘤生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- CDK4/6抑制剂 (CDK4/6i) 对乳腺癌等某些癌症有效.
- 耐药性的机制和CDK4/6i的更广泛的应用仍然不清楚.
研究的目的:
- 研究MYC在CDK4/6i耐药性中的作用.
- 确定治疗策略,以克服MYC驱动的抵抗.
主要方法:
- 使用了不同MYC水平的癌症细胞系 (膀,前列腺,乳腺).
- 评估了MYC放大对CDK4/6i敏感性的影响.
- 研究了涉及KLHL42和RB1.1的MYC诱导耐药性的分子机制.
- 选和评估了一种MYC降解化合物 (A80.2HCl).
- 在体内进行了结合CDK4/6i和A80.2H.Cl的瘤生长研究.
主要成果:
- 在多种癌症类型中,MYC放大赋予了对CDK4/6i的内在抵抗力.
- MYC上调 KLHL42,导致 RB1 降解和 CDK4/6i 抵抗.
- 化合物A80.2HCl在纳米分子度下有效降解MYC.
- A80.2HCl恢复了RB1水平,并使MYC增强癌细胞对CDK4/6i重新敏感.
- 与CDK4/6i和A80.2HCl的联合治疗在体内显著抑制瘤生长.
结论:
- MYC放大是对CDK4/6抑制剂耐药性的关键机制.
- 用A80.2HCl等化合物准MYC降解可以克服这种阻力.
- 组合疗法对治疗对CDK4/6i耐药的MYC驱动癌症具有前景.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K


